The stock has a 36-month beta value of 3.45. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 8 as “hold,” and 0 as “sell.”
The public float for VIGL is 27.42M, and at present, short sellers hold a 1.48% of that float. On June 05, 2025, the average trading volume of VIGL was 864.16K shares.
VIGL) stock’s latest price update
The stock price of Vigil Neuroscience Inc (NASDAQ: VIGL) has plunged by -0.19 when compared to previous closing price of 7.90, but the company has seen a 0.06% gain in its stock price over the last five trading sessions. prnewswire.com reported 2025-06-04 that PHILADELPHIA, June 4, 2025 /PRNewswire/ — The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Vigil Neuroscience, Inc. (“Vigil”) (NASDAQ: VIGL) shareholders. Click here for additional information about your legal rights and options: https://kaskelalaw.com/case/vigil-neuroscience/ On May 21, 2025, Vigil announced that it had agreed to be acquired by Sanofi at an upfront price of $8.00 per share in cash plus a non-transferable contingent value right (CVR) worth an additional $2.00 in cash upon the achievement of certain milestones.
VIGL’s Market Performance
Vigil Neuroscience Inc (VIGL) has experienced a 0.06% rise in stock performance for the past week, with a 227.18% rise in the past month, and a 235.53% rise in the past quarter. The volatility ratio for the week is 0.33%, and the volatility levels for the past 30 days are at 27.65% for VIGL. The simple moving average for the last 20 days is 52.70% for VIGL stock, with a simple moving average of 172.16% for the last 200 days.
Analysts’ Opinion of VIGL
Many brokerage firms have already submitted their reports for VIGL stocks, with Stifel repeating the rating for VIGL by listing it as a “Hold.” The predicted price for VIGL in the upcoming period, according to Stifel is $8 based on the research report published on May 28, 2025 of the current year 2025.
Morgan Stanley gave a rating of “Underweight” to VIGL, setting the target price at $4 in the report published on December 19th of the previous year.
VIGL Trading at 148.23% from the 50-Day Moving Average
After a stumble in the market that brought VIGL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.82% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at VIGL starting from Budd Haeberlein Samantha L., who purchase 12,000 shares at the price of $1.71 back on Dec 19 ’24. After this action, Budd Haeberlein Samantha L. now owns 12,000 shares of Vigil Neuroscience Inc, valued at $20,520 using the latest closing price.
Magovcevic-Liebisch Ivana, the President and CEO of Vigil Neuroscience Inc, purchase 5,000 shares at $1.68 during a trade that took place back on Dec 19 ’24, which means that Magovcevic-Liebisch Ivana is holding 222,687 shares at $8,400 based on the most recent closing price.
Stock Fundamentals for VIGL
The total capital return value is set at -1.2. Equity return is now at value -102.70, with -74.69 for asset returns.
Based on Vigil Neuroscience Inc (VIGL), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -4.19.
Currently, EBITDA for the company is -83.8 million with net debt to EBITDA at 0.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.97.
Conclusion
To sum up, Vigil Neuroscience Inc (VIGL) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
